Evidence map›Paper›PMID 38685411›Full record

Observational studyJournal of the American Academy of Dermatology2024

Low incidence of invasive fungal infection and risk factors in a large observational cohort of patients initiating tumor necrosis factor-alpha inhibitors for dermatologic conditions.

Ian Hennessee, Kaitlin Benedict, Nathan C Bahr, Shari R Lipner, Jeremy A W Gold

Erratum issuedOpen access · greenAbstract readLetterObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Journal of the American Academy of Dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Ian HennesseeMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: ihennessee@cdc.gov.
Kaitlin BenedictMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.
Nathan C BahrDivision of Infectious Diseases, Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Shari R LipnerDepartment of Dermatology, Weill Cornell Medicine, New York, New York.
Jeremy A W GoldMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.
Centers for Disease Control and Prevention · USCornell University · USEpidemic Intelligence Service · USUniversity of Kansas Medical Center · US

Funding

Novel Diagnostic Development for TB Meningitis and HistoplasmosisK23NS110470 · NINDS · UNIVERSITY OF MINNESOTA · PI BAHR, NATHAN · 2019 to 2023
$1.0M
NINDS NIH HHS K23 NS110470
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Tumor Necrosis Factor-alphaAdultAgedCohort StudiesFemaleHumansIncidenceInvasive Fungal InfectionsMaleMiddle AgedRetrospective StudiesRisk FactorsSkin DiseasesTumor Necrosis Factor-alphabiologicscandidiasiscoccidioidomycosiscorticosteroidsesophageal candidiasishidradenitis suppurativahistoplasmosisinvasive fungal infectionspsoriasispyoderma gangrenosumseborrheic dermatitisStevens-Johnson syndromeTNF-alpha inhibitors

Identifiers

PMID38685411
PMCPMC11343648
OpenAlexW4395703185

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.